Pathway network analyses for autism reveal multisystem involvement, major overlaps with other diseases and convergence upon MAPK and calcium signaling

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Wen, Ya ^a,b,c   Alshikho, Mohamad J ^a,b   Herbert, Martha R ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Higher Synthesis Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; RAF PROTEIN; RAS PROTEIN; BIOLOGICAL MARKER;

ARTICLE; AUTISM; CALCIUM SIGNALING; COMORBIDITY; HEART DISEASE; HUMAN; INFORMATION PROCESSING; METABOLIC DISORDER; NEOPLASM; PATHOPHYSIOLOGY; PLEIOTROPY; BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETICS; SIGNAL TRANSDUCTION;

AUTISTIC DISORDER; BIOMARKERS; CALCIUM SIGNALING; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; MAP KINASE SIGNALING SYSTEM;

EID: 84963718872     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153329     Document Type: Article

References (54)

1. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature. 2013; 493: 327-337. doi:10.1038/nature11860 PMID: 233252159.
2. Sakai Y, Shaw CA, Dawson BC, Dugas DV, Al-Mohtaseb Z, Hill DE, et al. Protein Interactome Reveals Converging Molecular Pathways Among Autism Disorders. Sci Transl Med. 2011; 3: 86ra49-86ra49. doi:10.1126/scitranslmed.3002166 PMID: 2165382.
3. Cristino AS, Williams SM, Hawi Z, An J-Y, Bellgrove MA, Schwartz CE, et al. Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system. Mol Psychiatry. 2014; 19: 294-301. doi:10.1038/mp.2013.16 PMID: 23439483.
4. Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, et al. Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism. Cell. 2013; 155: 1008-1021. doi:10.1016/j.cell.2013.10.031 PMID: 24267887.
5. Skafidas E, Testa R, Zantomio D, Chana G, Everall IP, Pantelis C. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry. 2014; 19: 504-510. doi:10.1038/mp.2012.126 PMID: 22965006.
6. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc NatlAcad Sci. 2005; 102: 15545-15550. doi:10.1073/pnas.0506580102 PMID: 16199517.
7. Vivar JC, Pemu P, Mcpherson R, Ghosh S. Redundancy control in pathway databases (ReCiPa): An application for improving gene-set enrichment analysis in Omics studies and "Big data" biology. Omics J Integr Biol. 2013; 17: 414-22. doi:10.1089/omi.2012.0083.
8. Mascia F, Denning M, Kopan R, Yuspa SH. The Black Box Illuminated: Signals and Signaling. J Invest Dermatol. 2012; 132: 811-819. doi:10.1038/jid.2011.406 PMID: 22170487.
9. Regulation of MAP kinase activity by peptide receptor signalling pathway: Paradigms of multiplicity. Cell Signal. 2001; 13: 777-785. doi:10.1016/S0898-6568(01)00192-9 PMID: 11583913.
10. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EWT, Chang F, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007; 1773: 1263-84. PMID: 17126425.
11. King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009; 38: 1224-1234. doi:10.1093/ije/dyp261 PMID: 19737791.
12. Hertz-Picciotto I, Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiol Camb Mass. 2009; 20: 84-90. doi:10.1097/EDE.0b013e3181902d15.
13. Lam KSL, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: A review of the literature. Res Dev Disabil. 2006; 27: 254-289. doi:10.1016/j.ridd.2005.03.003 PMID: 16002261.
14. Hoischen A, Krumm N, Eichler EE. Prioritization of neurodevelopmental disease genes by discovery of new mutations. Nat Neurosci. 2014; 17: 764-772. doi:10.1038/nn.3703 PMID: 24866042.
15. Pao GM, Zhu Q, Perez-Garcia CG, Chou S- J, Suh H, Gage FH, et al. Role of BRCA1 in brain development. Proc Natl Acad Sci U S A. 2014; 111: E1240- E8. doi:10.1073/pnas.1400783111 PMID: 24639535.
16. Ronan JL, Wu W, Crabtree GR. From neural development to cognition: unexpected roles for chromatin. Nat Rev Genet. 2013; 14: 440-440. doi: 10.1038/nrg3508.
17. Darling NJ, Cook SJ. The role of MAPK signalling pathways in the response to endoplasmic reticulum stress. Biochim Biophys Acta BBA-Mol Cell Res. 2014; 1843: 2150-2163. doi:10.1016/j.bbamcr.2014.01.009.
18. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007; 26: 3279-3290. doi:10.1038/sj.onc.1210421 PMID: 17496922.
19. Adviento B, Corbin IL, Widjaja F, Desachy G, Enrique N, Rosser T, et al. Autism traits in the RASopathies. J Med Genet. 2014; 51: 10-20. doi:10.1136/jmedgenet-2013-101951 PMID: 24101678.
20. Faridar A, Jones-Davis D, Rider E, Li J, Gobius I, Morcom L, et al. Mapk/Erk activation in an animal model of social deficits shows a possible link to autism. Mol Autism. 2014; 5: 57. doi:10.1186/2040-2392-5-57 PMID: 25874073.
21. Pucilowska J, Vithayathil J, Tavares EJ, Kelly C, Karlo JC, Landreth GE. The 16p11.2 deletion mouse model of autism exhibits altered cortical progenitor proliferation and brain cytoarchitecture linked to the ERK MAPK pathway. J Neurosci Off J Soc Neurosci. 2015; 35: 3190-200. doi:10.1523/JNEUROSCI.4864-13.2015.
22. Kalkman HO. Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders. Neurosci Biobehav Rev. 2012; 36: 2206-2213. doi:10.1016/j.neubiorev.2012.07.008 PMID: 22884480.
23. Gehart H, Kumpf S, Ittner A, Ricci R. MAPK signalling in cellular metabolism: stress or wellness? EMBO Rep. 2010; 11: 834-840. doi:10.1038/embor.2010.160 PMID: 20930846.
24. DeBerardinis RJ. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med. 2008; 10: 767-777. doi:10.1097/GIM.0b013e31818b0d9b PMID: 18941420.
25. Egan AM, Dreyer ML, Odar CC, Beckwith M, Garrison CB. Obesity in young children with autism spectrum disorders: prevalence and associated factors. Child Obes Print. 2013; 9: 125-31. doi:10.1089/chi.2012.0028.
26. Tyler CV, Schramm SC, Karafa M, Tang AS, Jain AK. Chronic Disease Risks in Young Adults with Autism Spectrum Disorder: Forewarned Is Forearmed. Am J Intellect Dev Disabil. 2011; 116: 371-380. doi:10.1352/1944-7558-116.5.371 PMID: 21905805.
27. Kohane IS, McMurry A, Weber G, MacFadden D, Rappaport L, Kunkel L, et al. The Co-Morbidity Burden of Children and Young Adults with Autism Spectrum Disorders (Comorbidities of Autism Spectrum Disorder). PLoS ONE. 2012; 7: E33224. doi:10.1371/journal.pone.0033224 PMID: 22511918.
28. Bilder DA, Bakian AV, Viskochil J, Clark EAS, Botts EL, Smith KR, et al. Maternal prenatal weight gain and autism spectrum disorders. Pediatrics. 2013; 132: E1276-83. doi:10.1542/peds.2013-1188 PMID: 24167172.
29. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry J Ment Sci. 2009; 195: 7-14. doi:10.1192/bjp.bp.108.051672Acad Sci. 2005; 102: 15545-15550. doi: 10.1073/pnas.0506580102 PMID: 16199517.
30. Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, Hansen RL, et al. Maternal Metabolic Conditions and Risk for Autism and Other Neurodevelopmental Disorders. Pediatrics. 2012; 129: E1121- e1128. doi:10.1542/peds.2011-2583 PMID: 22492772.
31. Wittkowski KM, Sonakya V, Bigio B, Tonn MK, Shic F, Ascano M, et al. A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism. Transl Psychiatry. 2014; 4: E354. doi:10.1038/tp.2013.124 PMID: 24473445.
32. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. Ca V1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism. Cell. 2004; 119: 19-31. doi:10.1016/j.cell.2004.09.011 PMID: 15454078.
33. Lu AT-H, Dai X, Martinez-Agosto JA, Cantor RM. Support for calcium channel gene defects in autism spectrum disorders. Mol Autism. 2012; 3: 18. doi:10.1186/2040-2392-3-18 PMID: 23241247.
34. Ming X, Julu POO, Brimacombe M, Connor S, Daniels ML. Reduced cardiac parasympathetic activity in children with autism. Brain Dev. 2005; 27: 509-516. doi:10.1016/j.braindev.2005.01.003 PMID: 16198209.
35. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Ercument Cicek A, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014; 515: 209-215. doi:10.1038/nature13772 PMID: 25363760.
36. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000; 1: 11-21. doi:10.1038/35036035 PMID: 11413485.
37. Cartwright EJ, Mohamed T, Oceandy D, Neyses L. Calcium signaling dysfunction in heart disease. Bio- Factors Oxf Engl. 2011; 37: 175-81. doi:10.1002/biof.149.
38. Kranias EG, Bers DM. Calcium and cardiomyopathies. Subcell Biochem. 2007; 45: 523-37. PMID: 18193651.
39. Catterall WA. Voltage-gated calcium channels. Cold Spring Harb Perspect Biol. 2011; 3: A003947. doi:10.1101/cshperspect.a003947 PMID: 21746798.
40. Wallace JA, Pitarresi JR, Sharma N, Palettas M, Cuitiño MC, Sizemore ST, et al. Protein Kinase C Beta in the Tumor Microenvironment Promotes Mammary Tumorigenesis. Front Oncol. 2014; 4. doi:10.3389/fonc.2014.00087.
41. Li L, Park L, Li L, Rask-Madsen L, Mima L, Qi L, et al. Induction of Vascular Insulin Resistance and Endothelin-1 Expression and Acceleration of Atherosclerosis by the Overexpression of Protein Kinase C-β Isoform in the Endothelium. Circ Res. 2013; 113: 418-427. doi:10.1161/CIRCRESAHA.113.301074PMID: 23759514.
42. Shao B, Bayraktutan U. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β. Diabetes Obes Metab. 2013; 15: 993-999. doi:10.1111/dom.12120 PMID: 23617822.
43. Araki S-I, Ng DPK, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, et al. Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus. J Am Soc Nephrol JASN. 2003; 14: 2015-24. PMID: 12874455.
44. Chibber R, Ben-Mahmud BM, Mann GE, Zhang JJ, Kohner EM. Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: A mechanism underlying capillary occlusion in diabetic retinopathy. Diabetes. 2003; 52: 1519-27. PMID: 12765965.
45. Dhandapany PS, Razzaque MA, Muthusami U, Kunnoth S, Edwards JJ, Mulero-Navarro S, et al. RAF1 mutations in childhood-onset dilated cardiomyopathy. Nat Genet. 2014; 46: 635-639. doi:10.1038/ng.2963PMID: 24777450.
46. Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet. 2007; 39: 1013-1017. doi:10.1038/ng2078 PMID: 17603482.
47. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer. 2007; 7: 281-294. doi:10.1038/nrc2110 PMID: 17384583.
48. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia. 2001; 44: 659-673. doi:10.1007/s001250051675PMID: 11440359.
49. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. THe familial risk of autism. JAMA. 2014; 311: 1770-1777. doi:10.1001/jama.2014.4144 PMID: 24794370.
50. Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: A systematic review. Transl Psychiatry. 2014; 4: E360. doi:10.1038/tp.2014.4 PMID: 24518398.
51. Corrales MA, Herbert MR. Autism and Environmental Genomics: Synergistic Systems Approaches to Autism Complexity. Oxford University Press; 2011.
52. Banerjee-Basu S, Packer A. SFARI Gene: An evolving database for the autism research community. Dis Model Mech. 2010; 3: 133-135. doi:10.1242/dmm.005439 PMID: 20212079.
53. Ouwenga RL, Dougherty J. Fmrp targets or not: long, highly brain-expressed genes tend to be implicated in autism and brain disorders. Mol Autism. 2015; 6. doi:10.1186/s13229-015-0008-1.
54. Abrahams BS, Arking DE, Campbell DB, Mefford HC, Morrow EM, Weiss LA, et al. SFARI Gene 2.0: A community-driven knowledgebase for the autism spectrum disorders (ASDs). Mol Autism. 2013; 4: 36- 36. doi:10.1186/2040-2392-4-36PMID: 24090431.